ADAR1 Capital Management reports $14,530 InMed Pharmaceuticals share purchase
INM•ADAR1 Capital Management raised its indirect stake in InMed Pharmaceuticals to 945,924 common shares after purchasing 10,903 shares for $14,530.
1. Reported purchases
ADAR1 Capital Management purchased 10,903 InMed Pharmaceuticals common shares at prices of $1.3277, $1.33 and $1.3283 per share, raising its indirect stake to 945,924 shares. Manager Daniel Schneeberger reported the holdings as part of a group filing.
